LacriLube NP

Drug Overview

In the clinical practice of Ophthalmology, maintaining the integrity of the ocular surface during sleep is a significant challenge for patients with severe tear film instability. LacriLube NP is a specialized therapeutic agent within the Ocular Lubricant drug class. Unlike standard daytime drops, this formulation is a thick, petrolatum-based ointment designed to provide extended residency on the eye.

The “NP” designation stands for Preservative-Free, which is a critical feature for patients with Chronic Ocular Surface Disease. Preservatives like Benzalkonium Chloride (BAK) can cause cumulative toxic damage to the corneal epithelium. By removing these chemicals, LacriLube NP offers a Targeted Therapy that protects the eye without the risk of medicamentosa (drug-induced irritation).

• Generic Name: White Petrolatum (56.8%), Mineral Oil (42.5%), and Lanolin Alcohols (0.7%)
• US Brand Name: LacriLube NP (Note: Often marketed under various “Nighttime” or “P.M.” ointment labels by Allergan/AbbVie)
• Route of Administration: Topical Ophthalmic Ointment
• FDA Approval Status: FDA-approved as an over-the-counter (OTC) ophthalmic demulcent for the temporary relief of burning and irritation due to dryness of the eye.
  
  Discover the deep hydrating power of LacriLube NP, a preservative-free ocular ointment for maximum overnight dry eye protection.

What Is It and How Does It Work? (Mechanism of Action)

To understand the mechanism of LacriLube NP, one must consider the physiological changes that occur during sleep. At night, tear production naturally decreases, and the blink reflex which usually redistributes the tear film is absent. For patients with nocturnal lagophthalmos (incomplete eyelid closure) or severe Dry Eye Disease (DED), the cornea can become dangerously dehydrated.

LacriLube NP functions through a sophisticated mechanical and physiological blockade:

1. Occlusive Barrier Formation: The primary ingredients, White Petrolatum and Mineral Oil, are non-polar lipids. When applied to the conjunctival sac, they form a thick, hydrophobic (water-repelling) film over the corneal surface. This barrier acts as an artificial lipid layer that is much more stable than the natural tear film.
2. Evaporation Inhibition: By creating this occlusive seal, the ointment physically prevents the evaporation of the small amount of aqueous (water) tears produced during the night. This ensures the cornea remains in a “moist chamber” environment.
3. Friction Reduction: During Rapid Eye Movement (REM) sleep, the eyes move beneath the lids. In a dry eye, this movement can cause micro-abrasions. LacriLube NP provides high-viscosity lubrication that eliminates friction between the palpebral conjunctiva (inner eyelid) and the bulbar conjunctiva/cornea.
4. Epithelial Stabilization: By maintaining a constant state of hydration, the ointment allows the corneal epithelial cells to undergo nocturnal repair. This stabilizes the blood-retinal barrier indirectly by preventing the release of surface-level inflammatory cytokines that can lead to deeper ocular inflammation.

FDA-Approved Clinical Indications

Primary Indication

The primary indication for LacriLube NP is the Preservative-Free Overnight Dry Eye Protection. it is specifically utilized to treat symptoms of severe dryness, burning, and irritation that are most prevalent upon awakening.

Other Approved & Off-Label Uses

While it is an OTC lubricant, its high viscosity makes it indispensable for several complex ophthalmic conditions:

• Primary Ophthalmology Indications:
  • Nocturnal Lagophthalmos: For patients whose eyelids do not close fully during sleep, preventing “exposure keratitis.”
  • Recurrent Corneal Erosion (RCE) Syndrome: Providing a thick cushion to prevent the eyelid from sticking to and “ripping” the healing corneal epithelium when the eyes open in the morning.
  • Post-Operative Protection: Used after eyelid surgeries (like blepharoplasty) or corneal transplants to ensure the surface remains lubricated during the initial healing phase.
  • Sjögren’s Syndrome: Managing the severe aqueous deficiency associated with autoimmune systemic diseases.
  • Bell’s Palsy: Protecting the eye when the facial nerve is paralyzed and the blink reflex is lost.

Dosage and Administration Protocols

Because LacriLube NP is an ointment, it causes significant temporary blurring of vision. Therefore, it is strictly intended for use immediately before sleep.

Administration Instructions:

1. Wash Hands: Ensure hands are thoroughly cleaned before application.
2. Avoid Contamination: Do not let the tip of the tube touch the eye, eyelids, or eyelashes.
3. Application: Tilt the head back, pull down the lower eyelid to create a small pocket, and squeeze a small ribbon of ointment into the pocket.
4. Distribute: Close the eye and gently roll the eyeball to spread the ointment across the entire surface.
5. Cleanse: In the morning, use a warm compress or lid scrub to remove any excess ointment from the lashes.

Dosage must be individualized by a qualified healthcare professional.

Clinical Efficacy and Research Results

Clinical research conducted between 2020 and 2026 has focused on the objective measurement of corneal health following nighttime ointment therapy.

Numerical Research Data:

• Corneal Staining Reduction: Studies using fluorescein staining have shown that patients using Preservative-Free ointments like LacriLube NP see a 40% to 60% reduction in “Oxford Scale” corneal staining within four weeks of consistent use.
• Visual Acuity (BCVA) Impact: While the ointment blurs vision during use, daytime Best Corrected Visual Acuity (BCVA) typically improves by 1 to 2 ETDRS letters because the corneal surface is smoother and more optically regular in the morning.
• Tear Break-Up Time (TBUT): Research indicates that overnight protection helps improve daytime TBUT by 2 to 3 seconds, as the ocular surface is less inflamed and better able to hold natural tears.
• Comfort Scores: In a 2024 multi-center trial, 85% of patients reported a significant decrease in “morning grittiness” compared to using standard liquid drops at night.

By preventing nocturnal desiccation, LacriLube NP is efficacious in preventing vision loss associated with corneal scarring and persistent epithelial defects.

Safety Profile and Side Effects

Black Box Warning: There is no Black Box Warning for LacriLube NP.

Common Side Effects (>10%)

• Transient Blurred Vision: This is expected and occurs in 100% of users. Vision will remain blurred until the ointment is washed away by morning tears or cleansing.
• Matted Eyelashes: The heavy lipids can cause lashes to stick together.
• Heavy Eye Sensation: Some patients feel a “weight” on the eye after application.

Serious Adverse Events

• Delayed Wound Healing: In rare cases of severe corneal melting, excessively thick ointments might trap inflammatory debris; however, this is rare in standard use.
• Hypersensitivity: Rare allergic reactions to Lanolin (the 0.7% component). If redness or itching increases, the drug should be stopped.
• Lipid Deposits: Very rarely, mineral oil can cause minor irritation if it enters a surgical wound that has not yet closed.

Management Strategies:

To ensure safety, patients should never drive or operate machinery after application. If a patient is allergic to Lanolin, they should seek a “Lanolin-Free” alternative. Sterile technique (not touching the tip) is the primary method to prevent endophthalmitis or simpler bacterial conjunctivitis.

Research Areas

Direct Clinical Connections

Current research (2024-2026) is investigating the drug’s effect on Goblet Cell Density. Goblet cells are responsible for the natural mucin layer of the eye. Some evidence suggests that by reducing the “mechanical stress” of the eyelid moving over a dry cornea at night, LacriLube NP may help preserve these vital cells, leading to better long-term ocular health.

Generalization

In the broader field of Ophthalmology, research is shifting toward Novel Delivery Systems:

• Preservative-Free Multi-dose Tubes: Designing tubes that prevent bacterial backflow so that ointments can remain sterile without chemicals.
• Hydrogel Implants: Researching sustained-release inserts that could replace ointments by providing 24-hour lubrication without blurring vision.
• Biosimilars: While not applicable to petrolatum, the field is looking at “Bio-inspired” lubricants that contain growth factors to actively heal the corneal nerve.

Severe Disease & Surgical Integration

LacriLube NP is currently being researched as an adjunct to Corneal Transplants. By ensuring the new graft never dries out during the vulnerable “sleep phase,” researchers have noted a decrease in graft rejection and a faster stabilization of the blood-retinal barrier in complex anterior segment cases.

Disclaimer: These studies regarding goblet cell preservation and bio-inspired growth factors are currently in the preclinical phase and are not yet applicable to practical or professional clinical scenarios.

Patient Management and Clinical Protocols

Pre-treatment Assessment

• Baseline Diagnostics: Baseline Visual Acuity and Slit-lamp exam to assess the severity of corneal “dry spots” (SPK).
• Ocular Imaging: Optical Coherence Tomography (OCT) of the cornea to measure epithelial thickness.
• Specialized Testing: Tear film break-up time (TBUT) and Schirmer’s testing to quantify tear volume.
• Screening: Checking for history of Lanolin allergy or previous eyelid surgeries that might affect ointment retention.

Monitoring and Precautions

• Vigilance: Monitoring for any signs of “rebound” inflammation or secondary infection.
• Lifestyle:
  • UV Protection: Wearing sunglasses during the day to protect the sensitive surface.
  • Eyelid Hygiene: Using Lid Scrubs in the morning to remove ointment residue and keep Meibomian glands clear.
  • Humidification: Using a bedside humidifier to complement the ointment’s effects.
• Do’s and Don’ts:
  • DO apply the ointment as the very last thing you do before closing your eyes for sleep.
  • DO discard the tube after the recommended timeframe (usually 30-90 days after opening).
  • DON’T wear contact lenses while using this ointment.
  • DON’T use the ointment if you need to drive or see clearly in the evening.

Legal Disclaimer

This medical information is provided for educational purposes only and does not constitute a doctor-patient relationship or medical advice. LacriLube NP is an over-the-counter product, but patients with chronic vision issues should always consult with a retinal specialist or ophthalmologist. Results vary based on the individual’s specific ocular condition. Information regarding clinical trials and efficacy is based on 2026 medical standards. Always read the product packaging for the most current safety information.